rhDNase Eye Drops in Patients With Ocular Graft-Vs.-Host Disease

NCT02702518 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
58
Enrollment
OTHER
Sponsor class

Stopped The DSMB committee recommended closing the trial because of the COVID-19 risk in this "at-risk" oGVHD population if they came for study visits.

Conditions

Interventions

Sponsor

University of Illinois at Chicago

Collaborators